A phase II study to assess vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma (laBCC): The Vismodegib Neoadjuvant (VISMONEO) study.
Laurent Mortier
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche
Philippe Saiag
Consultant or Advisory Role - Roche
Marie Thérèse Leccia
Research Funding - Roche
Abdelkader Mahmoudi
Employment or Leadership Position - Roche
Liubinka Mirakovska
No relevant relationships to disclose
Damia Meddour
No relevant relationships to disclose
Alain Duhamel
No relevant relationships to disclose
Xavier Mirabel
No relevant relationships to disclose
Pierre Guerreschi
No relevant relationships to disclose